Omeros Corporation
NASDAQ:OMERBiotechnology
+$0.43 today
- Market cap
- $1.08B
- Beta
- 2.53
- P/E (TTM)
- 8.4
- EPS (TTM)
- $1.20
Volume 2.53M
Average 1.55M
OMER Total Current Liabilities
All obligations due within one year.
Omeros CorporationNASDAQ: OMER
Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total current liabilities falls 28.6% from a year ago
Total current liabilities stood at $59.44M at the end of Q1 FY2026, down 28.6% from a year earlier and down 23.9% from the prior quarter. Over 3 fiscal years it compounded at -17.0% a year.
Context
- Total current liabilities amounted to 20.8% of total assets at the end of Q1 FY2026, down 14.6 pp from a year earlier.
- Total current liabilities increased in 1 of the last 3 fiscal years.
What to watch
Whether total current liabilities keeps falling in the next quarterly balance sheet after a -28.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 78.06M USD
- Year-over-year change
- -1.8%
- 4-year CAGR
- +10.8%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 78.06M | -1.8% |
| FY2024 | 2024-12-31 | 79.53M | +49.2% |
| FY2023 | 2023-12-31 | 53.32M | -60.9% |
| FY2022 | 2022-12-31 | 136.38M | +163.3% |
| FY2021 | 2021-12-31 | 51.79M | — |
Total Current Liabilities vs competitors
How OMER compares with its peers on the latest reported figures
- OMER's Mar 2026 total current liabilities of $59.44M is the 6th highest of the 11 companies compared; the peer median is $52.18M.
- Its year-over-year change of -28.6% is the 10th highest of 11, against a peer median of -2.9%.
- Total current liabilities amounts to 20.8% of total assets for OMER, versus a peer median of 13.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $198M | -5.7% | +6.2% | 21.4% | |
| Mar 2026 | $95.94M | +73.0% | -3.9% | 44.0% | |
| Jun 2026 | $81.87M | -14.8% | +14.5% | 11.3% | |
| Jun 2026 | $70.99M | -0.6% | -7.8% | 6.5% | |
| Jun 2026 | $62.66M | -49.6% | +8.8% | 16.9% | |
| Mar 2026 | $59.44M | -28.6% | -17.0% | 20.8% | |
| Mar 2026 | $41.7M | -5.3% | +14.0% | 12.6% | |
| Mar 2026 | $35.15M | +28.5% | +18.8% | 8.7% | |
| Mar 2026 | $22.04M | +5.0% | +23.7% | 15.1% | |
| Mar 2026 | $12.11M | +30.5% | -4.4% | 4.8% | |
| Mar 2026 | $6.18M | -17.6% | -43.9% | 15.2% | |
| Peer median (excluding OMER) | $52.18M | -2.9% | +7.5% | 13.9% | |
Competitors are the stored peer set for OMER. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 100.81M | 11.01M | 7.11M | 3.4M | 9.66M |
| Short-term Investments | 56.46M | 183.91M | 164.74M | 86.73M | 162.14M |
| Net Receivables | 82.47M | 242.02M | 6.72M | 36.82M | 36.27M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 67K | 6.3M | 30.75M | 7.17M | 7.6M |
| Total Current Assets | 247.96M | 443.24M | 217.9M | 134.12M | 215.67M |
| Property, Plant & Equipment (Net) | 30.01M | 23.25M | 20.58M | 17.64M | 12.48M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 141.31M | 124.48M | 139.79M | 125.32M | 97.49M |
| Total Non-current Assets | 171.31M | 147.73M | 160.37M | 142.96M | 109.97M |
| Total Assets | 419.27M | 590.97M | 378.27M | 277.08M | 325.63M |
| Account Payables | 13.4M | 5.99M | 7.71M | 5.91M | 4.76M |
| Short-term Debt | 0 | 94.38M | 8.58M | 21M | 17.06M |
| Tax Payables | 338K | 4.87M | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 2.47M |
| Other Current Liabilities | 3.71M | 7.82M | 0 | 29.51M | 30.9M |
| Total Current Liabilities | 51.79M | 136.38M | 53.32M | 79.53M | 78.06M |
| Long-term Debt | 313.46M | 220.91M | 329.71M | 166.58M | 208.54M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.12M | 125.57M | 2.09M | 200.11M | 153.02M |
| Total Non-current Liabilities | 343.7M | 368.9M | 349.94M | 380.16M | 368.8M |
| Total Liabilities | 395.49M | 505.29M | 403.25M | 459.69M | 446.86M |
| Common Stock | 626K | 628K | 611K | 580K | 716K |
| Retained Earnings | (683.13M) | (635.72M) | (753.53M) | (910.35M) | (913.7M) |
| Accumulated OCI | 0 | 0 | (0) | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 23.78M | 85.68M | (24.98M) | (182.61M) | (121.23M) |
| Total Debt | 347.84M | 342.02M | 361.58M | 207.02M | 239.14M |
| Net Debt | 247.03M | 331.01M | 354.48M | 203.62M | 229.48M |
Omeros Corporation
NASDAQ:OMER
Intrinsic Alpha fair value
Locked
Current Price
$14.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.